https://www.selleckchem.com/products/CUDC-101.html
Conclusion The revision of the insulin therapy protocol reduced the variability of insulin concentration in preparations and avoided the administration of glycated derivatives potentially toxic for neonates. What is Known • Insulin preparation in NICUs is a risky task because it is a two-step preparation • Diluted in dextrose, insulin aspart is unstable, with formation of potentially toxic glycated derivatives What is New • This work proposes a new insulin therapy protocol validated by HPLC-UV for NICU allowing suppression of the forma
Like
Comment
Share
